Abstract
Acquired angioedema due to C1 inhibitor deficiency (C1-INH-AAE) is a very rare disease compared to Hereditary angioedema (HAE). There is a need for an updated characterisation of patients with C1-INH-AAE to understand the disease pathogenesis and optimise treatment. We describe the disease burden, long term prophylaxis (LTP) and C1-INH-AAE-associated diseases in a multicentre UK cohort.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
